Inhibitors; Protein tyrosine phosphatase; Purines; Triazole
Indexed keywords
2 AMINO 6 CHLORO 9 [[1 (2,3,4,6 TETRA O ACETYL B D GLUCOPYRANOSYL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 9H PURINE;
2 AMINO 6 CHLOROPURINE;
6 CHLORO 9 (PROP 2 YN 1 YL) 9H PURIN 2 AMINE;
6 CHLORO 9 [[1 (2,3,4,6 TETRA O ACETYL B D GLUCOPYRANOSYL) 1H 1,2,3 TRIAZOL 4 YL]METHYL] 2 [[[1 (2,3,4,6 TETRA O ACETYL B D GLUCOPYRANOSYL) 1H 1,2,3 TRIAZOL 4 YL]METHYL]AMINO] 9H PURINE;
6 CHLORO N 9 BIS[[1 [[3,4,5 TRIS(BENZYLOXY)TETRAHYDRO 6 METHOXY 2H PYRAN 2 YL]METHYL] 1H 1,2,3 TRIAZOL 4 YL]METHYL] 9H PURIN 2 AMINE;
6 CHLORO N,9 (PROP 2 YN 1 YL) 9H PURIN 2 AMINE;
6 CHLORO N,9 BIS[[1 [[3,4,5 TRIS(BENZYLOXY)TETRAHYDRO 6 METHOXY 2H PYRAN 2 YL]METHYL] 1H 1,2,3 TRIAZOL 4 YL]METHYL] 9H PURIN 2 AMINE;
6 METHOXY N,9 BIS[[1 [[3,4,5 TRIS(BENZYLOXY)TETRAHYDRO 6 METHOXY 2H PYRAN 2 YL]METHYL] 1H 1,2,3 TRIAZOL 4 YL]METHYL] 9H PURIN 2 AMINE;
6 METHOXY N,9 BIS[[1 [[3,4,5 TRIS(BENZYLOXY)TETRAHYDRO 6 METHOXY 2H PYRAN 2YL]METHYL] 1H 1,2,3 TRIAZOL 4 YL]METHYL] 9H PURIN 2 AMINE;
LEUKOCYTE ANTIGEN RELATED PROTEIN TYROSINE PHOSPHATASE;
METHYL 6 [4 [(2 AMINO 6 CHLORO 9H PURIN 9 YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL] 2,3,4 TRI O BENZYL 6 DEOXY A D GALACTOPYRANOSIDE;
METHYL 6 [4 [(2 AMINO 6 CHLORO 9H PURIN 9 YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL] 2,3,4 TRI O BENZYL 6 DEOXY A D GLUCOPYRANOSIDE;
METHYL 6 [4 [(2 AMINO 6 METHOXY 9H PURIN 9 YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL] 2,3,4 TRI O BENZYL 6 DEOXY A D GALACTOPYRANOSIDE;
METHYL 6 [4 [(2 AMINO 6 METHOXY 9H PURIN 9 YL)METHYL] 1H 1,2,3 TRIAZOL 1 YL] 2,3,4 TRI O BENZYL 6 DEOXY A D GLUCOPYRANOSIDE;
NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2;
PROTEIN TYROSINE PHOSPHATASE;
PROTEIN TYROSINE PHOSPHATASE 1B;
PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR;
PROTEIN TYROSINE PHOSPHATASE SHP 1;
PROTEIN TYROSINE PHOSPHATASE SHP 2;
PURINE DERIVATIVE;
UNCLASSIFIED DRUG;
ACETYLATION;
ARTICLE;
CHEMICAL MODIFICATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYCLOADDITION;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
IC 50;
CATALYTIC DOMAIN;
CLICK CHEMISTRY;
CYCLIZATION;
DRUG DESIGN;
ENZYME INHIBITORS;
GLYCOCONJUGATES;
GLYCOSYLATION;
HUMANS;
MOLECULAR STRUCTURE;
PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;
PURINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TRIAZOLES;
J. Zablocki, R. Kalla, T. Perry, V. Palle, V. Varkhedkar, D. Xiao, A. Piscopio, T. Maa, A. Gimbel, J. Hao, N. Chu, K. Leung, D. Zeng, Bioorg. Med. Chem. Lett. 2005, 15, 609.
S. Pal, W. J. Choi, S. A. Choe, C. L. Heller, Z.-G. Gao, M. Chinn, K. A. Jacobson, X. Hou, S. K. Lee, H. O. Kim, L. S. Jeong, Bioorg. Med. Chem. 2009, 17, 3733.
J. Romanowska, A. Szymańska-Michalak, J. Boryski, J. Stawiński, A. Kraszewski, R. Loddo, G. Sanna, G. Gollu, B. Secci, P. La Colla, Bioorg. Med. Chem. 2009, 17, 3489.
C. Wiesmann, K. J. Barr, J. Kung, J. Zhu, D. A. Erlanson, W. Shen, B. J. Fahr, M. Zhong, L. Taylor, M. Randal, R. S. McDowell, S. K. Hansen, Nat. Struct. Mol. Biol. 2004, 11, 730.
K. R. Guertin, L. Setti, L. Qi, R. M. Dunsdon, B. W. Dymock, P. S. Jones, H. Overton, M. Taylor, G. Williams, J. A. Sergi, K. Wang, Y. Peng, M. Renzetti, R. Boyce, F. Falcioni, R. Garippa, A. R. Oliver, Bioorg. Med. Chem. Lett. 2003, 13, 2895.